Johnson & Johnson

Moderna

AbbVie Inc.

American Red Cross

Gilead Sciences, Inc.

Arvita Tripati

VP operator. EIR. 30+ regulated AI products shipped.

Cohort 2

Cohort 1

Your product works. Your buyer liked the demo. So why did the deal go quiet? Often it's not the product, the pricing, or the competition. It's the messaging. This 3-minute scorecard tests whether messaging is your bottleneck covering 15 questions across five dimensions: clarity, buyer relevance, proof, trust, and conversion narrative. Most founders score 38-43 on their first attempt. Take it, find the gap, and fix the right problem.

Enterprise Messaging Scorecard


By the end of the course, you will have a Healthcare-Market Fit Map that tells you:

I make healthtech products buyable.

VP operator. EIR. 30+ regulated AI products shipped. AliveCor, LabCorp, Vineti, Korio, Clip Health

Healthtech founders are getting positive signals that never turn into revenue.Clinicians love the product. Advisors say the TAM is enormous. You might have a pilot running. And still, nothing is closing.So you fix the pitch. Hire a sales advisor. Ask another advisor which buyer to prioritize and get a different answer.The problem usually is not the pitch. It is that the market you chose cannot adopt what you built: not at this stage, not with your current evidence, not through the procurement and governance process your buyer actually requires.The buyer is not the user. The budget holder is not the champion. The evidence that excites a clinician is not the evidence that gets a contract signed.Healthcare-Market Fit gives you a framework to diagnose which market can actually buy, before you build the wrong proof strategy or spend another year in the wrong direction.

Healthcare has a hundred markets. Most founders pick the wrong one first.

Choose the right healthcare market before you waste a year on the wrong one

Know who owns the budget, the workflow, and the risk in your target market

Know what proof your target market requires before it will buy

Identify the trust and compliance barriers that could kill your deal

Make a clear call: pursue this market now, validate, or reposition

Wellness &amp; Healthtech founders getting interest but not traction who aren't sure if the problem is the product, the pitch, or the market.

Medtech &amp; TechBio founders getting interest but not traction who aren't sure if the problem is the product, the pitch, or the market.

Stop losing deals because your product team doesn't know what healthcare buyers need to see. Build the evidence that gets contracts signed.

VP operator. EIR. 30+ regulated products shipped. AliveCor, LabCorp, Vineti

You built something that works. A pharma, clinic, CRO, or payer ran a pilot. The champion loved it. Then everything went quiet.Most founders assume this is a sales problem. It's not. It's a product problem.The buyer can't explain what you do internally. The documents procurement needs don't exist. The pilot proved the product works but didn't produce the evidence anyone needs to justify a contract.This course covers the product-side work that makes healthcare deals closeable. Over three weeks (6 live sessions, Mon/Wed), you'll work on your actual company and your actual deals, building the positioning, documentation, and evidence that pharmaceutical companies, clinics, CROs, health systems, and payers need to see before they sign.This is not a sales methodology course. No pipeline frameworks, no closing techniques. It's built from 18 years on the product and operations side of healthtech, watching good products fail to get bought because nobody on the product team understood what the buyer actually needed to see.

Great pilot. No contract. That's not a sales problem.

Your buyer can explain what you do without calling you

Your stalled deal has a clear path forward

Your product team owns the documents buyers actually need.

Structure pilots that lead to contracts, not just good results

Know whether this deal is worth your team's next 90 days

Not an idea, not a prototypesomething that works

You have a Product

Healthtech founders who've built a working product and can't figure out why buyers won't sign after a successful pilot.

Product and technical leaders at healthtech companies who are being pulled into sales and feel out of their depth on the commercial side.

Operators at early-stage healthtech companies who've need to build the product-side evidence that actually closes deals.

Why Your Healthcare & Life Sciences Deals Stall - PM Time

VP operator. EIR. 30+ regulated  products shipped. AliveCor, LabCorp, Vineti

Whether your pilot stalled after a successful run or never got real traction with the right buyer, identify the gaps

Diagnose where your deal actually broke

Learn the signals that your pilot is on a path to a contract vs. a polite way for the buyer to keep evaluating you

Tell a real pilot from a free trial

Structure success metrics that produce the exact evidence your buyer's champion needs to get sign-off from procurement.

Build pilot criteria that close healthcare deals

Why Your Healthcare & Life Sciences Deals Stall - AM Time

Whether your pilot stalled after a successful run or never got real traction with the right buyer, identify the gaps.

Arvita Tripati makes healthtech products buyable.

Arvita Tripati

About Arvita

Courses

Healthcare-Market Fit Lab (PMF for Healthcare & Life Sciences)

Sold. Build Your Healthtech or Life Sciences Pilot Conversion Playbook

Lightning Lessons

Why Your Healthcare & Life Sciences Deals Stall - PM Time

Why Your Healthcare & Life Sciences Deals Stall - AM Time

Resources

Enterprise Messaging Scorecard